Market Outlook

By 2035, the U.S. Disposable Gastroenterology Devices Market is expected to reach approximately USD 10.45 billion, expanding at a CAGR of 9.60% during the forecast period 2026–2035. The market is estimated at USD 4.18 billion in 2025, compared with approximately USD 2.86 billion in 2021, USD 3.16 billion in 2022, USD 3.49 billion in 2023, and USD 3.82 billion in 2024. Historical analysis covers 2021–2024, and all market values in this report are expressed in USD billions.

The U.S. disposable gastroenterology devices industry sits at the intersection of high recurring procedure volume, infection-prevention priorities, endoscopy-suite labor economics, and continued migration of gastrointestinal care toward ambulatory settings. Unlike capital-heavy endoscopy systems, disposable gastrointestinal devices generate revenue every time a colonoscopy, upper gastrointestinal endoscopy, endoscopic ultrasound, enteroscopy, endoscopic retrograde cholangiopancreatography, polypectomy, biopsy, dilation, hemostasis, or therapeutic resection is performed.

The addressable procedure base is substantial. More than 23 million major adult gastrointestinal endoscopic procedures were estimated to have been performed annually in the United States in 2022, including approximately 15.5 million colonoscopies and 7.25 million upper endoscopies. This procedure density creates a structurally recurring market for biopsy forceps, snares, injection needles, retrieval devices, guidewires, sphincterotomes, cannulas, cytology brushes, hemostatic clips, dilation accessories, irrigation tubing, valves, caps, stents, procedure kits, single-use visualization devices, and increasingly complete disposable endoscopes.

Demand is evolving beyond the historical concept of disposables as inexpensive accessories attached to reusable capital equipment. A growing portion of purchasing decisions now considers infection control, reprocessing labor, turnaround time, inventory utilization, device traceability, procedural reliability, and the cost of cancelled or delayed cases. For high-risk and difficult-to-reprocess devices, the economic argument increasingly includes the avoided cost of reprocessing infrastructure and potential contamination events.

The U.S. Food and Drug Administration’s sustained attention to duodenoscope contamination has accelerated this change. The regulator has encouraged transition toward duodenoscopes incorporating disposable components or fully disposable designs where appropriate. This regulatory direction has changed hospital value-analysis discussions around single-use technology, particularly in ERCP, and has increased manufacturer investment in disposable imaging platforms.

The fastest expansion through 2035 is expected in single-use advanced endoscopy devices, disposable ERCP accessories, hemostasis and closure products, tissue-acquisition systems, complex polypectomy products, and standardized procedure kits. Traditional biopsy forceps, injection needles, guidewires, tubing, valves, and retrieval products will remain large-volume categories, but competitive differentiation will increasingly depend on clinical performance, procedural efficiency, packaging configuration, supply reliability, and integration with established endoscopy platforms.

 

Introduction

According to the U.S. Disposable Gastroenterology Devices Market Report, disposable gastroenterology devices comprise sterile, single-patient-use instruments and accessories employed during diagnostic and therapeutic gastrointestinal procedures. The market includes both conventional consumable accessories and next-generation single-use endoscopic imaging technologies.

The underlying clinical market is unusually attractive because gastrointestinal endoscopy combines high screening volumes with recurring diagnostic surveillance and therapeutic intervention. U.S. colorectal cancer screening recommendations generally begin at age 45 for average-risk adults and extend through age 75, creating a large recurring screening population. Colonoscopy is particularly important to the disposable-device ecosystem because a single procedure may use several consumables, including valves, biopsy devices, snares, injection needles, retrieval accessories, clips, irrigation products, and specimen-handling components.

Disease burden also supports demand outside colorectal screening. Gastroesophageal reflux disease, gastrointestinal bleeding, Barrett’s esophagus, inflammatory bowel disease, biliary obstruction, pancreatic disease, gastrointestinal cancers, dysphagia, strictures, liver disease, and small-bowel disorders create recurring diagnostic and interventional requirements. In 2025, approximately 154,000 new colorectal cancer cases were expected in the United States, reinforcing the long-term need for screening, surveillance, biopsy, polypectomy, localization, hemostasis, and therapeutic endoscopy.

Disposable products also align closely with U.S. endoscopy-suite economics. Reusable endoscopes require cleaning, high-level disinfection, drying, storage, maintenance, tracking, staff training, and documentation. Accessories designated for single use remove many of these processing requirements and allow procedure rooms to maintain standardized sterile inventory. Fully disposable scopes extend this concept further by converting a portion of endoscopy spending from capital and reprocessing expense into a predictable per-procedure operating cost.

The economic case varies by procedure. High-volume routine colonoscopy continues to favor reusable visualization platforms because reusable colonoscopes distribute capital cost across many cases. However, single-use technology can be more attractive when utilization is unpredictable, reprocessing resources are constrained, patient isolation is important, procedures occur outside a traditional endoscopy department, or contamination risk carries disproportionate clinical and financial consequences.

From 2026 through 2035, procurement is therefore expected to become increasingly hybrid. Large U.S. health systems are unlikely to replace every reusable gastrointestinal endoscope with disposable technology. Instead, they are expected to use single-use products selectively while expanding disposable accessories across virtually all gastrointestinal procedures. This hybrid model creates a broader and more sustainable commercial opportunity than a simple reusable-versus-disposable replacement thesis.

 

Key Market Drivers: What’s Fueling the U.S. Disposable Gastroenterology Devices Market Boom?

The first major market driver is the enormous U.S. gastrointestinal endoscopy procedure base. Colonoscopy alone generates more than 15 million annual procedures in recent national estimates. Upper gastrointestinal endoscopy adds more than seven million procedures, while ERCP, EUS, flexible sigmoidoscopy, and enteroscopy create additional demand for higher-value specialized accessories. Because most disposable devices are consumed once per case, procedure volume translates directly into recurring revenue.

Colorectal cancer screening provides another durable demand engine. Screening initiation at age 45 expanded the eligible population and has contributed to rising colonoscopy utilization among adults aged 40–49. Screening produces downstream procedures as well: positive stool-based tests frequently require colonoscopic follow-up, detected adenomas require removal and surveillance, and high-risk patients undergo more frequent examination. Every incremental procedure supports demand for patient-contact consumables.

A second major driver is infection prevention. Reusable gastrointestinal endoscopes are complex devices with narrow channels and components requiring validated cleaning and high-level disinfection. Duodenoscopes have received particular regulatory attention because their design historically created challenges in eliminating contamination. FDA recommendations encouraging innovative designs with disposable elements have strengthened the institutional case for single-use technology.

A third driver is labor economics. U.S. hospitals continue to face sterile-processing and clinical staffing pressure. Reprocessing a reusable endoscope requires trained staff, documentation, cleaning chemicals, automated endoscope reprocessors, drying and storage infrastructure, leak testing, preventive maintenance, and quality assurance. Disposable products reduce some of this operational dependency. The value proposition becomes strongest when health systems compare total cost per completed procedure rather than acquisition price alone.

A fourth driver is the migration of endoscopy toward ambulatory surgery centers and freestanding gastrointestinal facilities. These sites operate under different economics from tertiary hospitals. They prioritize rapid room turnover, predictable supply cost, lean staffing, smaller physical footprints, and low capital intensity. Disposable accessories already dominate much of their procedural workflow, while single-use imaging can become attractive for selected procedures or backup capacity.

A fifth driver is the expanding therapeutic role of gastrointestinal endoscopy. Modern endoscopy is no longer limited to visualization and basic biopsy. Endoscopists increasingly perform endoscopic mucosal resection, endoscopic submucosal dissection, advanced polypectomy, endoscopic closure, hemostasis, biliary stone management, stricture dilation, drainage, stent placement, tissue acquisition, and interventional EUS. These procedures require larger numbers of specialized single-use devices per case and carry higher average disposable revenue.

A sixth driver is hospital standardization. Large integrated delivery networks increasingly consolidate preferred vendors across multiple hospitals and outpatient centers. Standardization reduces SKU complexity, simplifies clinical training, strengthens negotiating leverage, and improves supply-chain resilience. Manufacturers capable of combining biopsy, polypectomy, hemostasis, ERCP, irrigation, retrieval, and procedure-room consumables within enterprise contracts can gain disproportionate share.

Finally, innovation itself is expanding the market. Single-use imaging is moving beyond early-generation concepts toward improved resolution, maneuverability, ergonomics, suction performance, and compatibility with therapeutic accessories. As clinical performance moves closer to reusable platforms, purchasing discussions become less focused on whether disposable devices can perform a procedure and more focused on where their workflow and infection-control benefits justify their economics.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in disposable gastroenterology is increasingly centered on converting complex endoscopic workflows into reliable, standardized single-use platforms.

One of the most visible innovations is the fully disposable gastrointestinal endoscope. Single-use duodenoscopes established the commercial precedent by targeting ERCP, where contamination concerns carry particular importance. Newer disposable gastroscope platforms are extending single-use technology into upper gastrointestinal procedures. Improvements in image quality, angulation, shaft stiffness, suction, irrigation, working-channel performance, and controller integration are reducing the performance gap with reusable systems.

A second area of innovation is disposable distal components. Manufacturers are developing removable or single-use caps, valves, biopsy valves, air/water components, and other patient-contact interfaces that allow a reusable core endoscope to retain its capital economics while reducing contamination risks associated with difficult-to-clean components. For many hospitals, this intermediate architecture may provide a practical balance between reusable and fully disposable systems.

Tissue acquisition is also becoming more sophisticated. Biopsy forceps are being optimized for larger and more consistent specimens, while EUS-guided fine-needle biopsy devices increasingly emphasize tissue architecture rather than cytology alone. Improved tissue acquisition can reduce repeat passes, improve pathology yield, and support molecular testing, making device performance economically relevant beyond the endoscopy suite.

Polypectomy technology is moving toward better control of large, flat, or difficult lesions. Specialized cold snares, hot snares, retrieval nets, graspers, injection needles, and defect-closure devices are being designed around advanced colorectal lesion management. As screening identifies more precancerous lesions, the disposable revenue opportunity increasingly depends on the therapeutic complexity of each case rather than procedure counts alone.

Hemostasis represents another premium innovation segment. Modern clips offer improved rotation, opening width, repositionability, and tissue capture. Hemostatic powders and other non-contact modalities are expanding the therapeutic toolkit for difficult bleeding scenarios. Hospitals evaluate these technologies through their ability to achieve immediate hemostasis, prevent rebleeding, avoid surgery, and reduce repeat endoscopy.

ERCP continues to be one of the most innovation-intensive disposable categories. Single-use sphincterotomes, guidewires, cannulas, extraction balloons, baskets, cytology brushes, stone-management tools, stents, and visualization catheters are integral to pancreaticobiliary intervention. Device developers increasingly compete on wire control, exchange efficiency, trackability, fluoroscopic visibility, atraumatic access, and compatibility within complex procedural workflows.

Another important development is procedure bundling. Instead of ordering each disposable independently, hospitals and ambulatory centers increasingly consider standardized kits containing valves, tubing, irrigation accessories, bite blocks, suction components, and other commonly used products. Procedure-specific kits can reduce setup time, inventory errors, wasted supplies, and nursing workload.

The next innovation cycle will therefore be shaped as much by workflow engineering as by individual-device performance. Vendors capable of reducing procedure-room complexity while maintaining predictable clinical performance will have an advantage in U.S. health-system contracting.

 

Segmentation Insights

The U.S. Disposable Gastroenterology Devices Market is segmented on the basis of product category, gastrointestinal procedure area, clinical function, end user, and geography.

 

By Product Category

Disposable Endoscopic Accessories and Procedure Consumables

Disposable accessories and routine procedure consumables represent the largest product category, accounting for an estimated USD 1.36 billion in 2025. This segment includes biopsy valves, irrigation tubing, air/water accessories, suction components, distal attachments, bite blocks, caps, cleaning-transition accessories, procedure kits, and other single-patient-use products required for routine endoscopy.

The category benefits from extremely high unit utilization and limited dependence on major capital replacement cycles. Purchasing decisions are heavily influenced by contract pricing, compatibility, packaging efficiency, supply availability, nursing preference, and health-system standardization.

Polypectomy and Endoscopic Resection Devices

Polypectomy and resection products represented approximately USD 0.81 billion in 2025. The segment includes cold snares, electrosurgical snares, injection needles, graspers, retrieval nets, electrosurgical knives, and supporting resection accessories.

Demand is tied closely to colorectal cancer screening and the increasing ability of advanced endoscopists to remove larger or more complex lesions endoscopically rather than referring patients directly to surgery. Cold-snare polypectomy continues to gain importance for appropriate lesions because of its procedural simplicity and favorable safety profile.

Tissue Acquisition Devices

Disposable tissue-acquisition products generated approximately USD 0.65 billion in 2025. Major products include biopsy forceps, cytology brushes, fine-needle aspiration devices, fine-needle biopsy devices, and specialty sampling instruments.

Growth is moving toward higher-quality histological sampling, especially in EUS and oncology-related procedures. Hospitals increasingly evaluate tissue-acquisition devices according to diagnostic yield, specimen adequacy, number of passes, needle handling, and downstream pathology requirements.

Hemostasis and Closure Devices

Hemostasis and closure products accounted for approximately USD 0.58 billion in 2025. The segment includes through-the-scope clips, advanced closure systems, ligation devices, hemostatic powders, injection devices, and supporting accessories.

This is an attractive value segment because successful endoscopic hemostasis can avoid surgical escalation, transfusion, repeat intervention, and extended hospitalization. Premium pricing can therefore be justified when a product demonstrates better deployment reliability or enables closure of technically difficult defects.

ERCP and Pancreaticobiliary Disposable Devices

ERCP-related disposables represented an estimated USD 0.49 billion in 2025. Products include sphincterotomes, guidewires, cannulas, extraction balloons, retrieval baskets, stents, cytology devices, drainage products, stone-management accessories, and single-use visualization systems.

Although ERCP procedure volume is much lower than colonoscopy, disposable spending per procedure is materially higher because multiple specialized devices may be required within one case. The segment is therefore commercially important for Boston Scientific, Cook Medical, Olympus, and other advanced endoscopy suppliers.

Fully Disposable Endoscopes and Single-Use Visualization Devices

Fully disposable gastrointestinal endoscopes and associated visualization devices represented approximately USD 0.29 billion in 2025, making the category smaller in absolute revenue but the fastest-growing product segment.

Growth is being driven by single-use duodenoscopes, disposable gastroscopes, ultrathin systems, and specialized visualization catheters. The segment is expected to achieve double-digit expansion through 2035 as image quality improves and health systems develop more precise patient-selection algorithms for disposable technology.

 

By Gastrointestinal Procedure Area

Lower Gastrointestinal Endoscopy and Colonoscopy

Lower GI procedures represent the largest procedural segment, contributing an estimated 43% of 2025 market revenue. The enormous colonoscopy base supports repetitive demand for biopsy forceps, snares, clips, injection needles, retrieval products, irrigation accessories, caps, and procedure-room consumables.

Commercial opportunity is shifting toward therapeutic colonoscopy. As more polyps are detected and removed during screening, manufacturers can increase revenue per case through differentiated resection and defect-management technologies.

Upper Gastrointestinal Endoscopy

Upper GI endoscopy accounts for approximately 23% of the market. Demand includes biopsy products, injection needles, hemostasis devices, dilation accessories, retrieval tools, foreign-body devices, feeding-access accessories, caps, and increasingly single-use gastroscopes.

Upper GI procedures are particularly important in bleeding management, Barrett’s esophagus surveillance, dysphagia evaluation, gastric disease, and oncology.

ERCP

ERCP represents approximately 14% of disposable-device revenue despite substantially lower procedure volume. High disposable intensity makes it one of the most valuable procedures on a per-case basis.

A single ERCP can consume multiple guidewires, cannulation devices, sphincterotomes, balloons, baskets, stents, drainage devices, and visualization accessories. Complex cases therefore create substantial commercial value.

Endoscopic Ultrasound and Advanced Interventional Endoscopy

EUS and advanced interventional procedures represent approximately 11% of market revenue. Fine-needle biopsy, fine-needle aspiration, access needles, guidewires, drainage devices, stents, electrosurgical delivery technologies, and other advanced accessories drive this category.

The segment is expected to outperform routine diagnostic endoscopy because therapeutic EUS is moving into procedures previously requiring interventional radiology or surgery.

Small-Bowel Endoscopy, Enteroscopy and Other GI Procedures

The remaining 9% includes enteroscopy, capsule-delivery support, flexible sigmoidoscopy, specialized motility-related procedures, and other gastrointestinal applications.

Although individually smaller, these procedures create attractive specialty niches where manufacturers can command premium pricing through unique device compatibility and procedural utility.

 

By Clinical Function

Diagnostic Sampling and Tissue Acquisition

Diagnostic sampling represents one of the most durable functions in gastrointestinal care. Biopsy forceps, brushes, aspiration needles, biopsy needles, and related accessories are consumed across millions of procedures annually.

The future of this category will increasingly be linked to precision oncology and advanced pathology. Devices capable of producing larger, intact, diagnostically useful specimens may gain share even when their unit price is higher.

Polyp Removal and Endoscopic Resection

Resection devices are expanding as endoscopists treat larger and more complex lesions. Cold-snare systems, electrosurgical snares, resection knives, injection needles, graspers, and specimen-retrieval devices form the core of the segment.

The shift from surgery toward organ-preserving endoscopic therapy strengthens long-term demand.

Hemostasis and Defect Closure

Hemostasis and closure technologies are strategically important because gastrointestinal bleeding can rapidly escalate into emergency admission, transfusion, repeat endoscopy, interventional radiology, or surgery.

Manufacturers that demonstrate reliable placement, strong tissue capture, ease of rotation, and compatibility with difficult anatomical positions can sustain premium pricing.

Access, Dilation and Device Delivery

This segment includes guidewires, dilators, balloons, cannulas, overtubes, introducers, and other devices required to reach, traverse, or treat gastrointestinal structures.

Growth is supported by increasingly complex minimally invasive procedures where stable device access becomes essential to procedural success.

Drainage, Stenting and Pancreaticobiliary Therapy

Disposable stents, delivery systems, drainage accessories, stone-management devices, guidewires, sphincterotomes, and related technologies form a high-value therapeutic segment.

Demand is supported by biliary obstruction, pancreatic disease, strictures, stones, malignancy, and advanced EUS-guided drainage procedures.

Irrigation, Fluid Management and Infection-Control Accessories

This function includes sterile irrigation tubing, valves, connectors, water-bottle systems, suction products, biopsy valves, caps, and procedure kits.

These devices carry lower individual prices but generate high recurring volume and are strategically important for manufacturers seeking broad account penetration.

 

By End User

Ambulatory Surgery Centers and Freestanding Endoscopy Centers

Ambulatory and freestanding gastrointestinal facilities represent the largest end-user opportunity by disposable unit volume. These settings perform large numbers of routine colonoscopies and upper GI procedures and are structurally aligned with single-use consumables.

Purchasing priorities emphasize predictable case cost, rapid turnover, minimal inventory complexity, reliable delivery, and standardized procedural packs. Products that save nursing preparation time can generate significant operational value even if their unit acquisition cost is modestly higher.

Hospitals and Integrated Health Systems

Hospitals remain the dominant buyers of premium disposable gastroenterology devices used in complex ERCP, EUS, gastrointestinal bleeding, advanced resection, inpatient endoscopy, emergency procedures, and high-risk patients.

Large systems increasingly purchase through enterprise contracts and group purchasing organizations. Vendor selection often depends on total portfolio breadth, physician preference, training support, product availability, and measurable clinical differentiation.

Academic Medical Centers and Tertiary GI Centers

Academic centers represent a smaller share of national procedure volume but have disproportionate influence on technology adoption. They are early adopters of disposable duodenoscopes, advanced EUS devices, novel hemostasis systems, endoscopic resection tools, and emerging single-use imaging technologies.

Clinical trials and physician training conducted at these institutions can influence downstream adoption throughout community health systems.

Gastroenterology Practices and Office-Based Facilities

Physician-owned gastroenterology practices represent a meaningful procurement segment, particularly where procedures are performed within affiliated endoscopy facilities.

These buyers are highly cost conscious and frequently evaluate disposables through contribution margin per procedure. Products that combine ease of use, low waste, contract visibility, and reliable reimbursement-compatible workflows are favored.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Disposable Gastroenterology Devices Market is geographically divided into the South, West, Northeast, and Midwest. Regional demand varies according to population scale, colorectal cancer burden, Medicare-age demographics, hospital and ambulatory endoscopy capacity, gastroenterologist density, academic-center concentration, payer mix, and adoption of advanced endoscopic procedures.

The South is the largest regional market, while the West is expected to record the fastest CAGR through 2035. The Northeast remains particularly important for premium advanced-endoscopy technologies, while the Midwest provides a substantial recurring market built around large integrated health systems and mature community gastroenterology networks.

South

The South represented approximately USD 1.48 billion in 2025, or about 35.4% of U.S. disposable gastroenterology device revenue, and is projected to approach USD 3.78 billion by 2035, representing an implied CAGR of approximately 9.83%.

The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, Maryland, Tennessee, Kentucky, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, West Virginia, Delaware, and the District of Columbia under the regional framework used for this analysis.

Texas is one of the largest individual U.S. opportunities because of its population scale, major medical centers, large community hospital networks, rapidly expanding suburbs, and strong ASC development. The state had more than 31 million residents in 2025 and is estimated to account for approximately USD 0.38–0.42 billion of disposable GI device demand.

Florida is structurally attractive because of its large older population. More than five million Florida residents were aged 65 or older in recent census estimates, supporting high demand for colorectal screening, gastrointestinal bleeding management, pancreaticobiliary intervention, and cancer surveillance. Florida represents an estimated USD 0.28–0.32 billion market.

Georgia and North Carolina are becoming increasingly important as population growth, hospital expansion, and physician investment strengthen outpatient endoscopy capacity. North Carolina combines growing metropolitan markets with sophisticated academic centers, while Georgia benefits from Atlanta’s large regional referral ecosystem.

Virginia, Maryland, Tennessee, and South Carolina provide substantial procedure bases, while Kentucky, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, and West Virginia carry meaningful gastrointestinal disease and colorectal cancer burdens. Access can be more uneven in rural portions of these states, creating opportunities for standardized disposables, regional referral centers, and technologies that reduce dependency on complex reprocessing infrastructure.

The South’s combination of population growth, aging demographics, high procedure volume, and aggressive outpatient expansion should keep it the largest regional revenue pool through 2035.

West

The West accounted for approximately USD 0.95 billion in 2025 and is forecast to reach approximately USD 2.67 billion by 2035, representing the fastest regional CAGR at roughly 10.89%.

The region includes California, Arizona, Washington, Colorado, Oregon, Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the dominant state market. With approximately 39.4 million residents in 2025, the state combines enormous procedure volume with leading academic medical centers, advanced endoscopy programs, ambulatory networks, and an innovation-oriented provider environment. California is estimated to represent approximately USD 0.42–0.47 billion in 2025 disposable gastroenterology device revenue.

California is particularly important for single-use imaging, advanced tissue acquisition, EUS, complex polypectomy, endoscopic resection, and novel hemostasis technologies because large academic institutions frequently evaluate new technologies early.

Arizona and Nevada are attractive growth markets because population expansion and aging demographics are raising demand for colorectal screening and therapeutic endoscopy. Colorado and Utah combine rapidly growing metropolitan populations with strong integrated health systems, while Washington and Oregon support sophisticated outpatient and hospital GI programs.

Idaho, Montana, Wyoming, New Mexico, Alaska, and Hawaii represent smaller absolute markets, but geographic dispersion creates specific value propositions for predictable single-use inventory and technologies that reduce dependence on centralized reprocessing capacity.

The West is expected to gain national market share as adoption moves toward high-value single-use endoscopy, advanced outpatient procedures, and technologically differentiated therapeutic disposables.

Northeast

The Northeast represented approximately USD 0.96 billion in 2025 and is projected to reach approximately USD 2.25 billion by 2035, an implied CAGR of approximately 8.89%.

The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Maine, New Hampshire, Vermont, Rhode Island, and other Northeast markets according to the report’s regional convention.

New York is the region’s largest market. The state combines approximately 20 million residents with a dense hospital ecosystem and numerous advanced gastrointestinal programs. New York is particularly important for ERCP, EUS, gastrointestinal oncology, advanced polypectomy, bariatric endoscopy, and academic technology evaluation.

Pennsylvania represents another major opportunity because of its substantial population and large integrated health systems. New Jersey benefits from high physician density, affluent commercially insured populations, and proximity to major metropolitan referral markets.

Massachusetts carries influence well beyond its population size because Boston is a major academic and clinical research hub. Novel tissue-acquisition devices, advanced resection technologies, endoscopic closure products, single-use imaging technologies, and interventional EUS devices frequently gain early clinical visibility through institutions in this market.

Connecticut, Rhode Island, New Hampshire, Maine, and Vermont contribute smaller absolute revenue but maintain mature endoscopy infrastructure and relatively high utilization among older patient populations.

Growth in the Northeast will be slightly slower than in the South and West because population expansion is more moderate. Nevertheless, the region should remain one of the country’s most important premium-device markets because of complex procedural mix and evidence-driven adoption.

Midwest

The Midwest represented approximately USD 0.79 billion in 2025 and is projected to reach approximately USD 1.75 billion by 2035, corresponding to an implied CAGR of approximately 8.28%.

The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois is the largest Midwest market and benefits from Chicago’s concentration of academic medical centers, large health systems, and community gastroenterology networks. Ohio is another strategically important market because of its large health systems and extensive specialist infrastructure.

Michigan, Indiana, Wisconsin, and Missouri provide substantial recurring demand for colonoscopy, upper GI endoscopy, gastrointestinal bleeding management, and routine therapeutic accessories. Minnesota is particularly important from an industry perspective because of its medical-technology ecosystem and sophisticated provider base.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota are smaller markets but demonstrate the relevance of standardized disposable products in regional referral models where patients may travel considerable distances for advanced procedures.

The Midwest is unlikely to outperform the West or South in percentage growth, but its integrated delivery networks, stable endoscopy volumes, and large community-hospital footprint make it a durable contracting market for broad disposable portfolios.

 

Key Market Players

The U.S. disposable gastroenterology devices competitive landscape combines diversified global medtech companies with specialized endoscopy manufacturers and single-use technology innovators.

Some of the key participants operating across the U.S. ecosystem include Boston Scientific Corporation, Olympus Corporation, Cook Medical, STERIS, Medtronic, Ambu A/S, CONMED Corporation, Micro-Tech Endoscopy USA, FUJIFILM Healthcare Americas Corporation, PENTAX Medical, Merit Medical Systems, Cardinal Health, Becton, Dickinson and Company, Teleflex Incorporated, Hobbs Medical, Diversatek Healthcare, EvoEndo, Creo Medical, EndoSound, Taewoong Medical USA, Q3 Medical Devices, Grena, Changzhou New Med Micro-Medtech, and Jiangsu Vedkang Medical Science and Technology.

Boston Scientific holds one of the strongest strategic positions because its portfolio spans ERCP, biliary intervention, single-use visualization, hemostasis, tissue acquisition, polypectomy, dilation, stents, and advanced endoscopy. Its EXALT single-use duodenoscope established a significant precedent for fully disposable GI visualization.

Olympus remains highly influential because of its installed endoscopy-system base and expanding portfolio of disposable therapeutic accessories. Its ability to integrate single-use cannulas, sphincterotomes, biopsy valves, electrosurgical knives, and other consumables with widely deployed endoscopy platforms provides an important cross-selling advantage.

Cook Medical maintains a strong position in pancreaticobiliary intervention, tissue acquisition, dilation, stenting, guidewire-based procedures, and advanced GI accessories. STERIS is particularly strong in routine procedural disposables, polypectomy, hemostasis, tissue acquisition, irrigation, tubing, valves, and infection-prevention products.

Ambu is strategically important because it represents the most direct pure-play challenge to reusable endoscopy economics. Its single-use gastroscope development demonstrates that disposable visualization is expanding beyond bronchoscopy and niche GI applications into more mainstream upper gastrointestinal workflows.

Micro-Tech Endoscopy has expanded aggressively in the U.S. through competitively positioned snares, clips, biopsy forceps, dilation products, stents, resection products, and other therapeutic accessories. Continued FDA clearances for disposable components and closure devices strengthen its ability to challenge established suppliers.

Competitive share through 2035 will be influenced less by individual catalog size and more by four capabilities: clinical differentiation, enterprise contracting, supply reliability, and procedural ecosystem integration. Manufacturers offering a broad portfolio can use bundled pricing and standardization to deepen account penetration, while focused innovators can still gain meaningful share by solving expensive clinical problems in advanced endoscopy.

 

Recent Developments

Recent developments reinforce the direction of the U.S. Disposable Gastroenterology Devices Market toward broader single-use visualization and increasingly sophisticated therapeutic accessories.

In April 2024, the FDA cleared the Ambu aScope Gastro Large with the aBox 2 platform, expanding the commercial presence of fully disposable upper gastrointestinal endoscopy technology in the United States. The clearance was strategically important because it extended single-use visualization into a procedure category historically dominated by reusable gastroscopes.

In June 2025, the FDA cleared the EvoEndo Single-Use Endoscopy System, adding another disposable platform to the U.S. GI environment. The development indicates that single-use gastrointestinal endoscopy is becoming a multi-manufacturer technology category rather than a limited niche.

In May 2025, Olympus received U.S. clearance for multiple single-use ERCP cannulas, reinforcing continued innovation within high-consumption pancreaticobiliary workflows. Additional 2025 clearances covered disposable sphincterotomes, biopsy valves, and single-use electrosurgical knives.

Micro-Tech also expanded its U.S. disposable-device portfolio through FDA clearances for products including a disposable distal cap in 2025 and additional disposable endoscopic components in 2026. Such developments demonstrate that innovation is occurring not only in complete scopes but also in the smaller components that determine workflow, infection control, and therapeutic capability.

The strategic implication is important. The market is not converging toward an all-disposable endoscopy model. Instead, manufacturers are creating a continuum ranging from reusable platforms with disposable accessories, to reusable scopes with disposable patient-contact components, to fully disposable visualization devices. Hospitals can therefore choose a configuration based on procedure economics, contamination risk, clinical complexity, staffing, and utilization.

Sustainability is emerging as a counterbalancing consideration. Health systems increasingly evaluate medical waste and lifecycle environmental impact when expanding single-use technology. Vendors that develop recycling programs, reduce packaging weight, improve material efficiency, or demonstrate credible lifecycle advantages are likely to gain procurement relevance.

 

Conclusion

The U.S. Disposable Gastroenterology Devices Market Size & Share is positioned to expand from approximately USD 4.18 billion in 2025 to USD 10.45 billion by 2035, representing a 9.60% CAGR during 2026–2035.

The underlying market is supported by an unusually strong recurring-volume model. Tens of millions of annual gastrointestinal procedures require sterile disposable products, and the number of consumables used per procedure is increasing as endoscopy becomes more therapeutic. Colorectal cancer screening provides the largest procedure-volume foundation, while ERCP, EUS, advanced polypectomy, hemostasis, endoscopic resection, drainage, and tissue acquisition generate disproportionate value per case.

The most attractive growth opportunities will emerge in single-use gastrointestinal endoscopes, ERCP disposables, advanced tissue-acquisition devices, hemostasis and closure products, complex polypectomy and resection technologies, pancreaticobiliary accessories, and procedure-specific consumable kits.

The commercial model will increasingly favor companies capable of proving both clinical and operational value. Hospitals and ambulatory centers are unlikely to adopt a disposable device simply because it is sterile. They will evaluate whether it improves reliability, reduces setup or reprocessing burden, supports faster case turnover, prevents procedural delays, lowers infection risk, or eliminates downstream cost.

Regional opportunity will remain concentrated in the South because of population scale and demographic growth. The West should record the fastest growth because of technology adoption and expanding outpatient infrastructure. The Northeast will remain a premium market for advanced therapeutic products, while the Midwest will provide stable recurring demand through large integrated health systems and community endoscopy networks.

Texas, California, Florida, New York, Pennsylvania, Illinois, Ohio, Georgia, North Carolina, New Jersey, Michigan, Massachusetts, Arizona, Virginia, and Washington will be particularly important state markets for manufacturers seeking national scale.

For clients evaluating this industry, the central strategic question is not whether disposables will capture more gastrointestinal procedure spending. That transition is already occurring. The more important questions are which device categories will justify premium pricing, how far fully disposable visualization will penetrate routine GI practice, where outpatient procedure migration will accelerate consumption, how health systems will balance infection prevention against sustainability, and which manufacturers can convert individual products into standardized enterprise-wide procedural ecosystems.

These factors will determine competitive advantage in the U.S. disposable gastroenterology devices industry through 2035.

 

TABLE OF CONTENT

1. U.S. Disposable Gastroenterology Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Disposable Gastroenterology Device Manufacturers
1.6.2. Component, Polymer, Electronics and Contract Manufacturing Suppliers
1.6.3. Hospitals and Integrated Health Systems
1.6.4. Gastroenterology Practices and Specialty GI Centers
1.6.5. Ambulatory Surgery Centers and Freestanding Endoscopy Centers
1.6.6. Group Purchasing Organizations, Distributors and Specialty Suppliers
1.6.7. Gastroenterologists, Advanced Endoscopists and Clinical Decision-Makers
1.6.8. Payers, FDA, CMS and Infection-Prevention Stakeholders

What this section provides: This section defines the U.S. disposable gastroenterology devices market boundary, study scope, methodology, assumptions, device inclusion criteria, and stakeholder ecosystem so clients understand how the market is measured and validated.

2. U.S. Disposable Gastroenterology Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size, 2021–2035 (US$ Billion)
2.8. CAGR Analysis, 2026–2035
2.9. High-Growth Opportunity Areas
2.10. Disposable Device Adoption versus Reusable Workflow Economics
2.11. Key Investment and Commercialization Themes

What this section provides: This section gives decision-makers a concise view of market size, historical development, forecast growth, disposable-device adoption, competitive intensity, procedure-driven demand, and the highest-priority commercial opportunities through 2035.

3. U.S. Disposable Gastroenterology Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. High U.S. Colonoscopy and Upper GI Endoscopy Procedure Volumes
3.1.2. Expansion of Colorectal Cancer Screening and Surveillance
3.1.3. Increasing Infection-Prevention Focus in Endoscopy
3.1.4. Growing Adoption of Single-Use Endoscopy Devices and Components
3.1.5. Expansion of Therapeutic Endoscopy, ERCP and EUS Procedures
3.1.6. Migration of Gastrointestinal Procedures to Ambulatory Settings
3.1.7. Endoscopy-Suite Labor, Reprocessing and Turnaround-Time Economics
3.1.8. Health-System Standardization of Procedure Consumables
3.2. Restraints and Their Impact Analysis
3.2.1. Per-Procedure Cost Premium of Fully Disposable Endoscopes
3.2.2. Strong Installed Base of Reusable Endoscopy Platforms
3.2.3. Environmental and Medical-Waste Concerns
3.2.4. GPO Pricing Pressure and Hospital Value-Analysis Scrutiny
3.2.5. Limited Clinical Need for Fully Disposable Scopes in High-Volume Routine Procedures
3.2.6. Product Compatibility and Physician Preference Barriers
3.3. Opportunities and Their Impact Analysis
3.3.1. Single-Use Duodenoscope and Gastroscope Expansion
3.3.2. Disposable Components for Reusable Endoscope Platforms
3.3.3. Advanced Polypectomy and Endoscopic Resection Devices
3.3.4. EUS-Guided Tissue Acquisition and Interventional EUS
3.3.5. Advanced Hemostasis and Endoscopic Closure
3.3.6. ERCP and Pancreaticobiliary Disposable Device Innovation
3.3.7. Procedure-Specific Disposable Kits and Bundled Consumables
3.3.8. Rural, Emergency and Decentralized Endoscopy Applications
3.4. Challenges and Their Impact Analysis
3.4.1. Balancing Infection Prevention with Sustainability Targets
3.4.2. Clinical Performance Parity with Reusable Devices
3.4.3. Supply-Chain Continuity for High-Volume Consumables
3.4.4. Hospital Formulary and Vendor-Consolidation Pressure
3.4.5. Physician Training and Product-Switching Resistance
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Endoscope Reprocessing Cost and Disposable Conversion Analysis
3.8. Ambulatory Endoscopy Center Economics
3.9. Hospital Procurement and Value-Analysis Behavior
3.10. Procedure-Level Disposable Revenue Opportunity Analysis

What this section provides: This section explains the clinical, economic, operational, infection-control, reimbursement, sustainability, and procurement forces shaping disposable GI device demand and helps clients evaluate both growth opportunities and execution risks.

4. U.S. Disposable Gastroenterology Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk from Reusable Devices
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Sterilization, Packaging and Manufacturing Ecosystem
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.8. FDA Endoscope Reprocessing and Infection-Control Landscape
4.9. CMS Reimbursement and Coverage Landscape
4.10. CPT, APC and ASC Payment Environment for GI Procedures
4.11. Import/Export Restrictions & Tariff Impact
4.12. Government Screening and Public Health Programs
4.13. Environmental Sustainability and Medical-Waste Analysis
4.14. Impact of Escalating Geopolitical and Supply-Chain Tensions
4.15. Hospital Value Analysis Committee Decision Framework
4.16. GPO Contracting and Vendor Standardization Trends

What this section provides: This section gives clients a comprehensive view of the external operating environment, including FDA requirements, reimbursement, procedure economics, pricing, supply chain, sustainability, infection prevention, and hospital purchasing behavior.

5. U.S. Disposable Gastroenterology Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
5.2. Disposable Endoscopic Accessories & Procedure Consumables
5.2.1. Biopsy Valves
5.2.2. Air/Water and Suction Valves
5.2.3. Irrigation Tubing and Water-System Accessories
5.2.4. Distal Caps and Attachments
5.2.5. Bite Blocks
5.2.6. Suction and Fluid-Management Accessories
5.2.7. Procedure Kits and Packs
5.2.8. Other Routine Disposable Accessories
5.3. Polypectomy & Endoscopic Resection Devices
5.3.1. Cold Snares
5.3.2. Hot/Electrosurgical Snares
5.3.3. Injection Needles
5.3.4. Endoscopic Resection Knives
5.3.5. Graspers and Retrieval Devices
5.3.6. Specimen Retrieval Nets
5.3.7. Other Resection Accessories
5.4. Tissue Acquisition Devices
5.4.1. Disposable Biopsy Forceps
5.4.2. Cytology Brushes
5.4.3. EUS Fine-Needle Aspiration Devices
5.4.4. EUS Fine-Needle Biopsy Devices
5.4.5. Specialty Sampling Devices
5.5. Hemostasis & Closure Devices
5.5.1. Through-the-Scope Hemostatic Clips
5.5.2. Advanced Endoscopic Closure Systems
5.5.3. Band Ligation Devices
5.5.4. Hemostatic Powders and Topical Agents
5.5.5. Disposable Injection Devices
5.5.6. Other Hemostasis Accessories
5.6. ERCP & Pancreaticobiliary Disposable Devices
5.6.1. Sphincterotomes
5.6.2. Guidewires
5.6.3. Cannulas
5.6.4. Stone Extraction Balloons
5.6.5. Retrieval Baskets
5.6.6. Cytology and Sampling Devices
5.6.7. Biliary and Pancreatic Stents
5.6.8. Drainage Accessories
5.6.9. Single-Use Cholangioscopy Accessories
5.7. Fully Disposable Endoscopes & Single-Use Visualization Devices
5.7.1. Single-Use Duodenoscopes
5.7.2. Single-Use Gastroscopes
5.7.3. Single-Use Colonoscopy Platforms
5.7.4. Single-Use Ultrathin Endoscopes
5.7.5. Single-Use Cholangioscopes
5.7.6. Other Disposable Visualization Devices

What this section provides: This section identifies the disposable GI device categories generating the highest recurring revenue and highlights the fastest-growing product opportunities across accessories, advanced therapeutic devices, ERCP products, and fully disposable visualization platforms.

6. U.S. Disposable Gastroenterology Devices Market – By Procedure Type

6.1. Overview
6.1.1. Segment Share Analysis, By Procedure Type, 2025 & 2035 (%)
6.1.2. Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
6.2. Colonoscopy & Lower GI Endoscopy
6.2.1. Screening Colonoscopy
6.2.2. Diagnostic Colonoscopy
6.2.3. Surveillance Colonoscopy
6.2.4. Therapeutic Colonoscopy
6.2.5. Flexible Sigmoidoscopy
6.3. Upper Gastrointestinal Endoscopy
6.3.1. Diagnostic EGD
6.3.2. Biopsy and Surveillance Procedures
6.3.3. Upper GI Hemostasis
6.3.4. Dilation Procedures
6.3.5. Foreign-Body Removal
6.3.6. Therapeutic Upper GI Endoscopy
6.4. Endoscopic Retrograde Cholangiopancreatography
6.4.1. Biliary Stone Management
6.4.2. Biliary Stricture Management
6.4.3. Pancreatic Intervention
6.4.4. Biliary and Pancreatic Stenting
6.4.5. Cholangioscopy-Assisted ERCP
6.5. Endoscopic Ultrasound
6.5.1. Diagnostic EUS
6.5.2. EUS-Guided Fine-Needle Aspiration
6.5.3. EUS-Guided Fine-Needle Biopsy
6.5.4. Interventional EUS
6.5.5. EUS-Guided Drainage Procedures
6.6. Advanced Endoscopic Resection & Therapeutic Procedures
6.6.1. Endoscopic Mucosal Resection
6.6.2. Endoscopic Submucosal Dissection
6.6.3. Complex Polypectomy
6.6.4. Endoscopic Defect Closure
6.6.5. Endoscopic Hemostasis
6.7. Enteroscopy & Other Gastrointestinal Procedures
6.7.1. Device-Assisted Enteroscopy
6.7.2. Small-Bowel Procedures
6.7.3. Feeding Access Procedures
6.7.4. Other GI Endoscopic Applications

What this section provides: This section helps clients understand disposable-device consumption by GI procedure type and identifies procedures with the strongest combination of volume growth, disposable intensity, clinical complexity, and revenue per case.

7. U.S. Disposable Gastroenterology Devices Market – By Clinical Function

7.1. Overview
7.1.1. Segment Share Analysis, By Clinical Function, 2025 & 2035 (%)
7.1.2. Market Size and Forecast, By Clinical Function, 2021–2035 (US$ Billion)
7.2. Diagnostic Sampling & Tissue Acquisition
7.2.1. Mucosal Biopsy
7.2.2. Cytology Sampling
7.2.3. EUS-Guided Tissue Acquisition
7.2.4. Oncology and Molecular Diagnostics Sampling
7.3. Polyp Removal & Endoscopic Resection
7.3.1. Cold Polypectomy
7.3.2. Electrosurgical Polypectomy
7.3.3. Endoscopic Mucosal Resection
7.3.4. Endoscopic Submucosal Dissection
7.4. Hemostasis & Defect Closure
7.4.1. Mechanical Hemostasis
7.4.2. Injection Hemostasis
7.4.3. Topical Hemostasis
7.4.4. Endoscopic Defect Closure
7.4.5. Variceal Ligation
7.5. Access, Dilation & Device Delivery
7.5.1. Guidewire Access
7.5.2. Balloon Dilation
7.5.3. Bougie and Mechanical Dilation
7.5.4. Cannulation and Introducer Devices
7.5.5. Overtubes and Access Devices
7.6. Drainage, Stenting & Pancreaticobiliary Therapy
7.6.1. Biliary Drainage
7.6.2. Pancreatic Drainage
7.6.3. GI Luminal Stenting
7.6.4. Stone Extraction
7.6.5. EUS-Guided Drainage
7.7. Visualization, Irrigation & Procedure Support
7.7.1. Disposable Endoscopic Visualization
7.7.2. Irrigation and Fluid Management
7.7.3. Suction and Valve Management
7.7.4. Infection-Control Components
7.7.5. Procedure Setup and Consumable Kits

What this section provides: This section evaluates disposable gastroenterology device demand according to the clinical task performed and helps clients identify functions where device differentiation can reduce complications, increase procedure efficiency, improve diagnostic yield, or expand therapeutic capability.

8. U.S. Disposable Gastroenterology Devices Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
8.2. Hospitals & Integrated Health Systems
8.2.1. Large Integrated Delivery Networks
8.2.2. Community Hospitals
8.2.3. Regional Referral Hospitals
8.3. Ambulatory Surgery Centers
8.3.1. Multispecialty ASCs
8.3.2. GI-Focused ASCs
8.4. Freestanding Endoscopy Centers
8.4.1. Independent Endoscopy Centers
8.4.2. Gastroenterology Group-Owned Centers
8.4.3. Health-System-Affiliated Endoscopy Centers
8.5. Academic Medical Centers & Tertiary GI Centers
8.5.1. Advanced Endoscopy Centers
8.5.2. Pancreaticobiliary Centers
8.5.3. GI Oncology and Research Centers
8.6. Gastroenterology Practices & Office-Based Facilities
8.6.1. Independent Gastroenterology Practices
8.6.2. Large Physician Group Practices
8.6.3. Office-Based Procedure Facilities

What this section provides: This section identifies the customer groups driving disposable GI device purchasing and explains how procedure mix, facility economics, infection-control priorities, throughput requirements, and purchasing leverage differ across U.S. care settings.

9. U.S. Disposable Gastroenterology Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
9.2. Direct Hospital & Health-System Procurement
9.2.1. Facility-Level Direct Contracts
9.2.2. System-Wide Standardization Contracts
9.3. Integrated Delivery Network Enterprise Contracts
9.3.1. Multi-Hospital IDN Agreements
9.3.2. Enterprise GI Service-Line Contracts
9.3.3. Bundled Portfolio Agreements
9.4. Group Purchasing Organization Contracts
9.4.1. National GPO Contracts
9.4.2. Regional GPO Contracts
9.4.3. Committed and Aggregated Purchasing Programs
9.5. Distributor & Specialty Supplier Sales
9.5.1. National Medical-Surgical Distributors
9.5.2. Specialty Endoscopy Distributors
9.5.3. Regional Distribution Networks
9.6. Ambulatory & Physician-Owned Facility Procurement
9.6.1. ASC Direct Procurement
9.6.2. Freestanding Endoscopy Center Procurement
9.6.3. Gastroenterology Practice Purchasing
9.6.4. Physician Purchasing Organizations

What this section provides: This section explains how disposable gastroenterology devices are purchased in the United States, including direct contracting, IDN standardization, GPO influence, distributor economics, bundled purchasing, and ASC procurement behavior.

10. U.S. Disposable Gastroenterology Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional GI Procedure Volume Analysis
10.1.4. Regional Gastroenterologist and Endoscopy Infrastructure Analysis
10.1.5. Regional ASC and Freestanding Endoscopy Center Analysis
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional Disposable versus Reusable Adoption Analysis
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers, Distributors & Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Clinical Function, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035
10.2.9.3. California Market Size and Forecast, By Procedure Type, 2021–2035
10.2.9.4. California Market Size and Forecast, By Clinical Function, 2021–2035
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035
10.2.10.3. Washington Market Size and Forecast, By Procedure Type, 2021–2035
10.2.10.4. Washington Market Size and Forecast, By Clinical Function, 2021–2035
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035
10.2.11.3. Arizona Market Size and Forecast, By Procedure Type, 2021–2035
10.2.11.4. Arizona Market Size and Forecast, By Clinical Function, 2021–2035
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035
10.2.12.3. Colorado Market Size and Forecast, By Procedure Type, 2021–2035
10.2.12.4. Colorado Market Size and Forecast, By Clinical Function, 2021–2035
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035
10.2.13.3. Oregon Market Size and Forecast, By Procedure Type, 2021–2035
10.2.13.4. Oregon Market Size and Forecast, By Clinical Function, 2021–2035
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035
10.2.14.3. Utah Market Size and Forecast, By Procedure Type, 2021–2035
10.2.14.4. Utah Market Size and Forecast, By Clinical Function, 2021–2035
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035
10.2.15.3. Nevada Market Size and Forecast, By Procedure Type, 2021–2035
10.2.15.4. Nevada Market Size and Forecast, By Clinical Function, 2021–2035
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035
10.2.16.3. New Mexico Market Size and Forecast, By Procedure Type, 2021–2035
10.2.16.4. New Mexico Market Size and Forecast, By Clinical Function, 2021–2035
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035
10.2.17.3. Idaho Market Size and Forecast, By Procedure Type, 2021–2035
10.2.17.4. Idaho Market Size and Forecast, By Clinical Function, 2021–2035
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035
10.2.18.3. Montana Market Size and Forecast, By Procedure Type, 2021–2035
10.2.18.4. Montana Market Size and Forecast, By Clinical Function, 2021–2035
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035
10.2.19.3. Wyoming Market Size and Forecast, By Procedure Type, 2021–2035
10.2.19.4. Wyoming Market Size and Forecast, By Clinical Function, 2021–2035
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035
10.2.20.3. Alaska Market Size and Forecast, By Procedure Type, 2021–2035
10.2.20.4. Alaska Market Size and Forecast, By Clinical Function, 2021–2035
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035
10.2.21.3. Hawaii Market Size and Forecast, By Procedure Type, 2021–2035
10.2.21.4. Hawaii Market Size and Forecast, By Clinical Function, 2021–2035
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers, Distributors & Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035
10.3.5. Northeast Region Market Size and Forecast, By Procedure Type, 2021–2035
10.3.6. Northeast Region Market Size and Forecast, By Clinical Function, 2021–2035
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035
10.3.9.3. New York Market Size and Forecast, By Procedure Type, 2021–2035
10.3.9.4. New York Market Size and Forecast, By Clinical Function, 2021–2035
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035
10.3.10.3. Massachusetts Market Size and Forecast, By Procedure Type, 2021–2035
10.3.10.4. Massachusetts Market Size and Forecast, By Clinical Function, 2021–2035
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035
10.3.11.3. New Jersey Market Size and Forecast, By Procedure Type, 2021–2035
10.3.11.4. New Jersey Market Size and Forecast, By Clinical Function, 2021–2035
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035
10.3.12.3. Pennsylvania Market Size and Forecast, By Procedure Type, 2021–2035
10.3.12.4. Pennsylvania Market Size and Forecast, By Clinical Function, 2021–2035
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035
10.3.13.3. Connecticut Market Size and Forecast, By Procedure Type, 2021–2035
10.3.13.4. Connecticut Market Size and Forecast, By Clinical Function, 2021–2035
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035
10.3.14.3. Maine Market Size and Forecast, By Procedure Type, 2021–2035
10.3.14.4. Maine Market Size and Forecast, By Clinical Function, 2021–2035
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035
10.3.15.3. Vermont Market Size and Forecast, By Procedure Type, 2021–2035
10.3.15.4. Vermont Market Size and Forecast, By Clinical Function, 2021–2035
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035
10.3.16.3. New Hampshire Market Size and Forecast, By Procedure Type, 2021–2035
10.3.16.4. New Hampshire Market Size and Forecast, By Clinical Function, 2021–2035
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035
10.3.17.3. Rhode Island Market Size and Forecast, By Procedure Type, 2021–2035
10.3.17.4. Rhode Island Market Size and Forecast, By Clinical Function, 2021–2035
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035
10.3.18.3. Delaware Market Size and Forecast, By Procedure Type, 2021–2035
10.3.18.4. Delaware Market Size and Forecast, By Clinical Function, 2021–2035
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers, Distributors & Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035
10.4.5. South Region Market Size and Forecast, By Procedure Type, 2021–2035
10.4.6. South Region Market Size and Forecast, By Clinical Function, 2021–2035
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035
10.4.9.3. Texas Market Size and Forecast, By Procedure Type, 2021–2035
10.4.9.4. Texas Market Size and Forecast, By Clinical Function, 2021–2035
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035
10.4.10.3. Florida Market Size and Forecast, By Procedure Type, 2021–2035
10.4.10.4. Florida Market Size and Forecast, By Clinical Function, 2021–2035
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035
10.4.11.3. Georgia Market Size and Forecast, By Procedure Type, 2021–2035
10.4.11.4. Georgia Market Size and Forecast, By Clinical Function, 2021–2035
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035
10.4.12.3. North Carolina Market Size and Forecast, By Procedure Type, 2021–2035
10.4.12.4. North Carolina Market Size and Forecast, By Clinical Function, 2021–2035
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035
10.4.13.3. Tennessee Market Size and Forecast, By Procedure Type, 2021–2035
10.4.13.4. Tennessee Market Size and Forecast, By Clinical Function, 2021–2035
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035
10.4.14.3. South Carolina Market Size and Forecast, By Procedure Type, 2021–2035
10.4.14.4. South Carolina Market Size and Forecast, By Clinical Function, 2021–2035
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035
10.4.15.3. Alabama Market Size and Forecast, By Procedure Type, 2021–2035
10.4.15.4. Alabama Market Size and Forecast, By Clinical Function, 2021–2035
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035
10.4.16.3. Mississippi Market Size and Forecast, By Procedure Type, 2021–2035
10.4.16.4. Mississippi Market Size and Forecast, By Clinical Function, 2021–2035
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035
10.4.17.3. Louisiana Market Size and Forecast, By Procedure Type, 2021–2035
10.4.17.4. Louisiana Market Size and Forecast, By Clinical Function, 2021–2035
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035
10.4.18.3. Arkansas Market Size and Forecast, By Procedure Type, 2021–2035
10.4.18.4. Arkansas Market Size and Forecast, By Clinical Function, 2021–2035
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035
10.4.19.3. Kentucky Market Size and Forecast, By Procedure Type, 2021–2035
10.4.19.4. Kentucky Market Size and Forecast, By Clinical Function, 2021–2035
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035
10.4.20.3. Oklahoma Market Size and Forecast, By Procedure Type, 2021–2035
10.4.20.4. Oklahoma Market Size and Forecast, By Clinical Function, 2021–2035
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035
10.4.21.3. Virginia Market Size and Forecast, By Procedure Type, 2021–2035
10.4.21.4. Virginia Market Size and Forecast, By Clinical Function, 2021–2035
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035
10.4.22.3. Maryland Market Size and Forecast, By Procedure Type, 2021–2035
10.4.22.4. Maryland Market Size and Forecast, By Clinical Function, 2021–2035
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035
10.4.23.3. West Virginia Market Size and Forecast, By Procedure Type, 2021–2035
10.4.23.4. West Virginia Market Size and Forecast, By Clinical Function, 2021–2035
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers, Distributors & Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035
10.5.5. Midwest Region Market Size and Forecast, By Procedure Type, 2021–2035
10.5.6. Midwest Region Market Size and Forecast, By Clinical Function, 2021–2035
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035
10.5.9.3. Illinois Market Size and Forecast, By Procedure Type, 2021–2035
10.5.9.4. Illinois Market Size and Forecast, By Clinical Function, 2021–2035
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035
10.5.10.3. Ohio Market Size and Forecast, By Procedure Type, 2021–2035
10.5.10.4. Ohio Market Size and Forecast, By Clinical Function, 2021–2035
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035
10.5.11.3. Michigan Market Size and Forecast, By Procedure Type, 2021–2035
10.5.11.4. Michigan Market Size and Forecast, By Clinical Function, 2021–2035
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035
10.5.12.3. Minnesota Market Size and Forecast, By Procedure Type, 2021–2035
10.5.12.4. Minnesota Market Size and Forecast, By Clinical Function, 2021–2035
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035
10.5.13.3. Indiana Market Size and Forecast, By Procedure Type, 2021–2035
10.5.13.4. Indiana Market Size and Forecast, By Clinical Function, 2021–2035
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035
10.5.14.3. Wisconsin Market Size and Forecast, By Procedure Type, 2021–2035
10.5.14.4. Wisconsin Market Size and Forecast, By Clinical Function, 2021–2035
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035
10.5.15.3. Missouri Market Size and Forecast, By Procedure Type, 2021–2035
10.5.15.4. Missouri Market Size and Forecast, By Clinical Function, 2021–2035
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035
10.5.16.3. Iowa Market Size and Forecast, By Procedure Type, 2021–2035
10.5.16.4. Iowa Market Size and Forecast, By Clinical Function, 2021–2035
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035
10.5.17.3. Kansas Market Size and Forecast, By Procedure Type, 2021–2035
10.5.17.4. Kansas Market Size and Forecast, By Clinical Function, 2021–2035
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035
10.5.18.3. Nebraska Market Size and Forecast, By Procedure Type, 2021–2035
10.5.18.4. Nebraska Market Size and Forecast, By Clinical Function, 2021–2035
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035
10.5.19.3. North Dakota Market Size and Forecast, By Procedure Type, 2021–2035
10.5.19.4. North Dakota Market Size and Forecast, By Clinical Function, 2021–2035
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035
10.5.20.3. South Dakota Market Size and Forecast, By Procedure Type, 2021–2035
10.5.20.4. South Dakota Market Size and Forecast, By Clinical Function, 2021–2035
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035

What this section provides: This section delivers detailed U.S. regional and state-level intelligence across all 50 states, helping clients identify procedure-volume hubs, high-growth disposable adoption markets, advanced-endoscopy clusters, outpatient expansion opportunities, procurement hotspots, and priority commercial territories.

11. U.S. Disposable Gastroenterology Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking
11.2.1. Product Portfolio Breadth
11.2.2. Single-Use Technology Positioning
11.2.3. Advanced Endoscopy Portfolio Strength
11.2.4. U.S. Distribution Reach
11.2.5. Hospital and ASC Contracting Strength
11.2.6. Regulatory and Innovation Pipeline
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Company Profiles
11.4.1. Boston Scientific Corporation
11.4.2. Olympus Corporation
11.4.3. Cook Medical
11.4.4. STERIS plc
11.4.5. Medtronic plc
11.4.6. Ambu A/S
11.4.7. CONMED Corporation
11.4.8. Micro-Tech Endoscopy USA, Inc.
11.4.9. FUJIFILM Healthcare Americas Corporation
11.4.10. PENTAX Medical
11.4.11. Merit Medical Systems, Inc.
11.4.12. Cardinal Health, Inc.
11.4.13. Becton, Dickinson and Company
11.4.14. Teleflex Incorporated
11.4.15. Hobbs Medical, Inc.
11.4.16. Diversatek Healthcare
11.4.17. EvoEndo, Inc.
11.4.18. Creo Medical Group plc
11.4.19. EndoSound, Inc.
11.4.20. Taewoong Medical USA
11.4.21. Q3 Medical Devices Limited
11.4.22. Grena Ltd.
11.4.23. Changzhou New Med Micro-Medtech Co., Ltd.
11.4.24. Jiangsu Vedkang Medical Science and Technology Co., Ltd.
11.4.25. EndoMed Systems GmbH

Note: Each company profile will include company overview, disposable gastroenterology device portfolio, U.S. market strategy, competitive positioning, distribution structure, product pipeline, FDA/regulatory developments, strategic collaborations, acquisitions, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, disposable GI portfolio positioning, single-use innovation intelligence, commercialization strategies, distribution strength, and strategic profiles of 25 relevant market participants.

12. U.S. Disposable Gastroenterology Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Fully Disposable Gastrointestinal Endoscopes
12.2.2. Single-Use Duodenoscope Platforms
12.2.3. Disposable Components for Reusable Endoscopes
12.2.4. Advanced Single-Use Tissue Acquisition Devices
12.2.5. Next-Generation Hemostasis and Closure Technologies
12.2.6. Advanced Endoscopic Resection Devices
12.2.7. Interventional EUS and Disposable Drainage Platforms
12.2.8. Smart Procedure Kits and Inventory Standardization
12.3. Disposable versus Reusable Endoscopy Penetration Outlook
12.4. Sustainability and Circular-Economy Outlook
12.5. Emerging Business Trends
12.6. Business Opportunities for Startups and Existing Players
12.7. Investment Prioritization Matrix
12.8. High-Growth Product Opportunity Matrix
12.9. High-Growth State Opportunity Matrix
12.10. Market White-Space Analysis

What this section provides: This section prepares clients for future shifts in disposable-device penetration, therapeutic endoscopy, single-use visualization, sustainability requirements, competitive structure, technology disruption, and investment opportunities through 2035.

13. U.S. Disposable Gastroenterology Devices Market: Strategic Recommendations

13.1. Recommendations for Disposable GI Device Manufacturers
13.2. Recommendations for Single-Use Endoscopy Technology Companies
13.3. Recommendations for Hospitals and Integrated Health Systems
13.4. Recommendations for Ambulatory Surgery Centers and Endoscopy Centers
13.5. Recommendations for Gastroenterology Practices
13.6. Recommendations for Investors and Private Equity Firms
13.7. Recommendations for Distributors and Channel Partners
13.8. Recommendations for New Entrants and Startups
13.9. U.S. Go-to-Market Strategy Considerations
13.10. GPO and IDN Contracting Strategy
13.11. Product Positioning and Portfolio Expansion Guidance
13.12. Pricing and Value-Based Selling Strategy
13.13. Clinical Evidence and Physician Adoption Strategy
13.14. State-Level Commercial Prioritization Strategy
13.15. Partnership, Licensing and M&A Opportunity Assessment

What this section provides: This section converts market intelligence into actionable recommendations for product development, commercialization, pricing, contracting, channel expansion, geographic prioritization, portfolio strategy, investment planning, and competitive differentiation.

14. U.S. Disposable Gastroenterology Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Estimation Limitation
14.4. Forecasting Limitation
14.5. Legal Disclaimer
14.6. Third-Party Data Disclaimer
14.7. Regulatory and Reimbursement Information Limitation

What this section provides: This section clarifies the report’s scope boundaries, market-estimation methodology limitations, forecasting assumptions, regulatory-information limitations, legal conditions, and data-use terms.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Disposable Gastroenterology Devices Market: Market Definition and Scope
TABLE 3: U.S. Disposable Gastroenterology Devices Market: Research Methodology Framework
TABLE 4: U.S. Disposable Gastroenterology Devices Market: Key Assumptions
TABLE 5: U.S. Disposable Gastroenterology Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Disposable Gastroenterology Devices Market: Stakeholder Analysis
TABLE 7: U.S. Disposable Gastroenterology Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Disposable Gastroenterology Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Disposable Gastroenterology Devices Market: Market Attractiveness Index
TABLE 10: U.S. Disposable Gastroenterology Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Disposable Gastroenterology Devices Market: Base Year Market Positioning, 2025
TABLE 12: U.S. Disposable Gastroenterology Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Disposable Gastroenterology Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 14: U.S. Disposable Gastroenterology Devices Market: High-Growth Opportunity Areas
TABLE 15: U.S. Disposable Gastroenterology Devices Market: Drivers; Impact Analysis
TABLE 16: U.S. Disposable Gastroenterology Devices Market: Restraints; Impact Analysis
TABLE 17: U.S. Disposable Gastroenterology Devices Market: Opportunities; Impact Analysis
TABLE 18: U.S. Disposable Gastroenterology Devices Market: Challenges; Impact Analysis
TABLE 19: U.S. Disposable Gastroenterology Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 20: U.S. Disposable Gastroenterology Devices Market: Clinical Workflow Economics Matrix
TABLE 21: U.S. Disposable Gastroenterology Devices Market: Endoscope Reprocessing Cost versus Disposable Conversion Matrix
TABLE 22: U.S. Disposable Gastroenterology Devices Market: Ambulatory Endoscopy Center Economics
TABLE 23: U.S. Disposable Gastroenterology Devices Market: Hospital Procurement & Value Analysis Behavior
TABLE 24: U.S. Disposable Gastroenterology Devices Market: Procedure-Level Disposable Revenue Opportunity
TABLE 25: U.S. Disposable Gastroenterology Devices Market: PESTEL Analysis
TABLE 26: U.S. Disposable Gastroenterology Devices Market: Porter’s Five Forces Analysis
TABLE 27: U.S. Disposable Gastroenterology Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 28: U.S. Disposable Gastroenterology Devices Market: Value Chain Analysis
TABLE 29: U.S. Disposable Gastroenterology Devices Market: Supply Chain Analysis
TABLE 30: U.S. Disposable Gastroenterology Devices Market: Sterilization, Packaging & Manufacturing Ecosystem
TABLE 31: U.S. Disposable Gastroenterology Devices Market: Application & Innovation Landscape
TABLE 32: U.S. Disposable Gastroenterology Devices Market: FDA Regulatory Framework Analysis
TABLE 33: U.S. Disposable Gastroenterology Devices Market: Endoscope Reprocessing & Infection-Control Landscape
TABLE 34: U.S. Disposable Gastroenterology Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 35: U.S. Disposable Gastroenterology Devices Market: CPT, APC & ASC Payment Environment
TABLE 36: U.S. Disposable Gastroenterology Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 37: U.S. Disposable Gastroenterology Devices Market: Government Screening & Public Health Programs
TABLE 38: U.S. Disposable Gastroenterology Devices Market: Sustainability & Medical-Waste Analysis
TABLE 39: U.S. Disposable Gastroenterology Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 40: U.S. Disposable Gastroenterology Devices Market: GPO Contracting & Vendor Standardization Trends
TABLE 41: U.S. Disposable Gastroenterology Devices Market: Product Category Snapshot, 2025
TABLE 42: Segment Dashboard; Definition and Scope, by Product Category
TABLE 43: U.S. Disposable Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 44: U.S. Disposable Gastroenterology Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 45: Disposable Endoscopic Accessories & Procedure Consumables Market Size and Forecast, 2021–2035
TABLE 46: Polypectomy & Endoscopic Resection Devices Market Size and Forecast, 2021–2035
TABLE 47: Tissue Acquisition Devices Market Size and Forecast, 2021–2035
TABLE 48: Hemostasis & Closure Devices Market Size and Forecast, 2021–2035
TABLE 49: ERCP & Pancreaticobiliary Disposable Devices Market Size and Forecast, 2021–2035
TABLE 50: Fully Disposable Endoscopes & Single-Use Visualization Devices Market Size and Forecast, 2021–2035
TABLE 51: U.S. Disposable Gastroenterology Devices Market: Procedure Type Snapshot, 2025
TABLE 52: Segment Dashboard; Definition and Scope, by Procedure Type
TABLE 53: U.S. Disposable Gastroenterology Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 54: U.S. Disposable Gastroenterology Devices Market: Segment Share Analysis, by Procedure Type, 2025 & 2035 (%)
TABLE 55: Colonoscopy & Lower GI Endoscopy Market Size and Forecast, 2021–2035
TABLE 56: Upper Gastrointestinal Endoscopy Market Size and Forecast, 2021–2035
TABLE 57: ERCP Market Size and Forecast, 2021–2035
TABLE 58: Endoscopic Ultrasound Market Size and Forecast, 2021–2035
TABLE 59: Advanced Endoscopic Resection & Therapeutic Procedures Market Size and Forecast, 2021–2035
TABLE 60: Enteroscopy & Other Gastrointestinal Procedures Market Size and Forecast, 2021–2035
TABLE 61: U.S. Disposable Gastroenterology Devices Market: Clinical Function Snapshot, 2025
TABLE 62: Segment Dashboard; Definition and Scope, by Clinical Function
TABLE 63: U.S. Disposable Gastroenterology Devices Market, by Clinical Function, 2021–2035 (US$ Billion)
TABLE 64: U.S. Disposable Gastroenterology Devices Market: Segment Share Analysis, by Clinical Function, 2025 & 2035 (%)
TABLE 65: Diagnostic Sampling & Tissue Acquisition Market Size and Forecast, 2021–2035
TABLE 66: Polyp Removal & Endoscopic Resection Market Size and Forecast, 2021–2035
TABLE 67: Hemostasis & Defect Closure Market Size and Forecast, 2021–2035
TABLE 68: Access, Dilation & Device Delivery Market Size and Forecast, 2021–2035
TABLE 69: Drainage, Stenting & Pancreaticobiliary Therapy Market Size and Forecast, 2021–2035
TABLE 70: Visualization, Irrigation & Procedure Support Market Size and Forecast, 2021–2035
TABLE 71: U.S. Disposable Gastroenterology Devices Market: End User Snapshot, 2025
TABLE 72: Segment Dashboard; Definition and Scope, by End User
TABLE 73: U.S. Disposable Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 74: U.S. Disposable Gastroenterology Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 75: Hospitals & Integrated Health Systems Market Size and Forecast, 2021–2035
TABLE 76: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035
TABLE 77: Freestanding Endoscopy Centers Market Size and Forecast, 2021–2035
TABLE 78: Academic Medical Centers & Tertiary GI Centers Market Size and Forecast, 2021–2035
TABLE 79: Gastroenterology Practices & Office-Based Facilities Market Size and Forecast, 2021–2035
TABLE 80: U.S. Disposable Gastroenterology Devices Market: Procurement Channel Snapshot, 2025
TABLE 81: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 82: U.S. Disposable Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 83: U.S. Disposable Gastroenterology Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 84: Direct Hospital & Health-System Procurement Market Size and Forecast, 2021–2035
TABLE 85: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035
TABLE 86: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035
TABLE 87: Distributor & Specialty Supplier Sales Market Size and Forecast, 2021–2035
TABLE 88: Ambulatory & Physician-Owned Facility Procurement Market Size and Forecast, 2021–2035
TABLE 89: U.S. Disposable Gastroenterology Devices Market: Regional Snapshot, 2025
TABLE 90: Segment Dashboard; Definition and Scope, by Geography
TABLE 91: U.S. Disposable Gastroenterology Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 92: U.S. Disposable Gastroenterology Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 93: U.S. Disposable Gastroenterology Devices Market: Regional GI Procedure Volume Analysis
TABLE 94: U.S. Disposable Gastroenterology Devices Market: Regional Endoscopy Infrastructure Analysis
TABLE 95: West Region U.S. Disposable Gastroenterology Devices Market: Regional Overview & Trends
TABLE 96: West Region U.S. Disposable Gastroenterology Devices Market: Key Manufacturers & Procurement Ecosystem
TABLE 97: West Region U.S. Disposable Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 98: West Region Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 99: West Region Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 100: West Region Market, by Clinical Function, 2021–2035 (US$ Billion)
TABLE 101: West Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 102: West Region Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 103: California Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 104: Washington Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 105: Arizona Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 106: Colorado Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 107: Oregon Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 108: Utah Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 109: Nevada Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 110: New Mexico Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 111: Idaho Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 112: Montana Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 113: Wyoming Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 114: Alaska Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 115: Hawaii Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 116: Northeast Region U.S. Disposable Gastroenterology Devices Market: Regional Overview & Trends
TABLE 117: Northeast Region U.S. Disposable Gastroenterology Devices Market: Key Manufacturers & Procurement Ecosystem
TABLE 118: Northeast Region U.S. Disposable Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 119: Northeast Region Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 120: Northeast Region Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 121: Northeast Region Market, by Clinical Function, 2021–2035 (US$ Billion)
TABLE 122: Northeast Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 123: Northeast Region Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 124: New York Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 125: Massachusetts Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 126: New Jersey Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 127: Pennsylvania Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 128: Connecticut Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 129: Maine Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 130: Vermont Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 131: New Hampshire Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 132: Rhode Island Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 133: Delaware Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 134: South Region U.S. Disposable Gastroenterology Devices Market: Regional Overview & Trends
TABLE 135: South Region U.S. Disposable Gastroenterology Devices Market: Key Manufacturers & Procurement Ecosystem
TABLE 136: South Region U.S. Disposable Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 137: South Region Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 138: South Region Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 139: South Region Market, by Clinical Function, 2021–2035 (US$ Billion)
TABLE 140: South Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 141: South Region Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 142: Texas Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 143: Florida Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 144: Georgia Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 145: North Carolina Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 146: Tennessee Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 147: South Carolina Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 148: Alabama Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 149: Mississippi Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 150: Louisiana Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 151: Arkansas Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 152: Kentucky Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 153: Oklahoma Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 154: Virginia Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 155: Maryland Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 156: West Virginia Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 157: Midwest Region U.S. Disposable Gastroenterology Devices Market: Regional Overview & Trends
TABLE 158: Midwest Region U.S. Disposable Gastroenterology Devices Market: Key Manufacturers & Procurement Ecosystem
TABLE 159: Midwest Region U.S. Disposable Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 160: Midwest Region Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 161: Midwest Region Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 162: Midwest Region Market, by Clinical Function, 2021–2035 (US$ Billion)
TABLE 163: Midwest Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 164: Midwest Region Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 165: Illinois Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 166: Ohio Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 167: Michigan Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 168: Minnesota Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 169: Indiana Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 170: Wisconsin Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 171: Missouri Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 172: Iowa Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 173: Kansas Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 174: Nebraska Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 175: North Dakota Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 176: South Dakota Disposable Gastroenterology Devices Market Size and Forecast, 2021–2035
TABLE 177: U.S. Disposable Gastroenterology Devices Market: Competitive Landscape Snapshot, 2025
TABLE 178: U.S. Disposable Gastroenterology Devices Market: Key Company Market Share Analysis, 2025
TABLE 179: U.S. Disposable Gastroenterology Devices Market: Company Positioning Matrix
TABLE 180: U.S. Disposable Gastroenterology Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 181: U.S. Disposable Gastroenterology Devices Market: Single-Use Technology Positioning Matrix
TABLE 182: U.S. Disposable Gastroenterology Devices Market: Strategic Developments, Partnerships, M&A & Product Launches
TABLE 183: Boston Scientific Corporation: Company Profile
TABLE 184: Olympus Corporation: Company Profile
TABLE 185: Cook Medical: Company Profile
TABLE 186: STERIS plc: Company Profile
TABLE 187: Medtronic plc: Company Profile
TABLE 188: Ambu A/S: Company Profile
TABLE 189: CONMED Corporation: Company Profile
TABLE 190: Micro-Tech Endoscopy USA, Inc.: Company Profile
TABLE 191: FUJIFILM Healthcare Americas Corporation: Company Profile
TABLE 192: PENTAX Medical: Company Profile
TABLE 193: Merit Medical Systems, Inc.: Company Profile
TABLE 194: Cardinal Health, Inc.: Company Profile
TABLE 195: Becton, Dickinson and Company: Company Profile
TABLE 196: Teleflex Incorporated: Company Profile
TABLE 197: Hobbs Medical, Inc.: Company Profile
TABLE 198: Diversatek Healthcare: Company Profile
TABLE 199: EvoEndo, Inc.: Company Profile
TABLE 200: Creo Medical Group plc: Company Profile
TABLE 201: EndoSound, Inc.: Company Profile
TABLE 202: Taewoong Medical USA: Company Profile
TABLE 203: Q3 Medical Devices Limited: Company Profile
TABLE 204: Grena Ltd.: Company Profile
TABLE 205: Changzhou New Med Micro-Medtech Co., Ltd.: Company Profile
TABLE 206: Jiangsu Vedkang Medical Science and Technology Co., Ltd.: Company Profile
TABLE 207: EndoMed Systems GmbH: Company Profile
TABLE 208: U.S. Disposable Gastroenterology Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 209: U.S. Disposable Gastroenterology Devices Market: Disruptive Technologies Impact Matrix
TABLE 210: U.S. Disposable Gastroenterology Devices Market: Disposable versus Reusable Endoscopy Penetration Outlook
TABLE 211: U.S. Disposable Gastroenterology Devices Market: Sustainability & Circular-Economy Outlook
TABLE 212: U.S. Disposable Gastroenterology Devices Market: Emerging Business Trends
TABLE 213: U.S. Disposable Gastroenterology Devices Market: Business Opportunities for Startups & Existing Players
TABLE 214: U.S. Disposable Gastroenterology Devices Market: Investment Prioritization Matrix
TABLE 215: U.S. Disposable Gastroenterology Devices Market: High-Growth Product Opportunity Matrix
TABLE 216: U.S. Disposable Gastroenterology Devices Market: High-Growth State Opportunity Matrix
TABLE 217: U.S. Disposable Gastroenterology Devices Market: Market White-Space Analysis
TABLE 218: U.S. Disposable Gastroenterology Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 219: U.S. Disposable Gastroenterology Devices Market: Recommendations for Single-Use Endoscopy Companies
TABLE 220: U.S. Disposable Gastroenterology Devices Market: Recommendations for Hospitals & Health Systems
TABLE 221: U.S. Disposable Gastroenterology Devices Market: Recommendations for ASCs & Endoscopy Centers
TABLE 222: U.S. Disposable Gastroenterology Devices Market: Recommendations for Gastroenterology Practices
TABLE 223: U.S. Disposable Gastroenterology Devices Market: Recommendations for Investors & Private Equity Firms
TABLE 224: U.S. Disposable Gastroenterology Devices Market: Recommendations for Distributors & Channel Partners
TABLE 225: U.S. Disposable Gastroenterology Devices Market: Recommendations for New Entrants & Startups
TABLE 226: U.S. Disposable Gastroenterology Devices Market: U.S. Go-to-Market Strategy Considerations
TABLE 227: U.S. Disposable Gastroenterology Devices Market: GPO & IDN Contracting Strategy
TABLE 228: U.S. Disposable Gastroenterology Devices Market: Product Positioning & Portfolio Expansion Guidance
TABLE 229: U.S. Disposable Gastroenterology Devices Market: Pricing & Value-Based Selling Strategy
TABLE 230: U.S. Disposable Gastroenterology Devices Market: State-Level Commercial Prioritization Strategy
TABLE 231: U.S. Disposable Gastroenterology Devices Market: Scope Limitation
TABLE 232: U.S. Disposable Gastroenterology Devices Market: Data Use Limitation
TABLE 233: U.S. Disposable Gastroenterology Devices Market: Market Estimation Limitation
TABLE 234: U.S. Disposable Gastroenterology Devices Market: Forecasting Limitation
TABLE 235: U.S. Disposable Gastroenterology Devices Market: Legal Disclaimer
TABLE 236: U.S. Disposable Gastroenterology Devices Market: Third-Party Data Disclaimer
TABLE 237: U.S. Disposable Gastroenterology Devices Market: Regulatory & Reimbursement Information Limitation

List of Figures

FIGURE 1: U.S. Disposable Gastroenterology Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Disposable Gastroenterology Devices Market Ecosystem
FIGURE 4: Stakeholder Ecosystem Analysis
FIGURE 5: U.S. Disposable Gastroenterology Devices Market Size, Historical Trend Analysis, 2021–2024
FIGURE 6: U.S. Disposable Gastroenterology Devices Market Size, Forecast & Trend Analysis, 2026–2035
FIGURE 7: U.S. Disposable Gastroenterology Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Clinical Workflow Economics Framework
FIGURE 12: Disposable versus Reusable Endoscopy Cost Framework
FIGURE 13: Endoscope Reprocessing Workflow & Cost Structure
FIGURE 14: Hospital Value Analysis & Procurement Decision Framework
FIGURE 15: Procedure-Level Disposable Revenue Opportunity Map
FIGURE 16: PESTEL Analysis
FIGURE 17: Porter’s Five Forces Analysis
FIGURE 18: Value Chain Analysis
FIGURE 19: Supply Chain Analysis
FIGURE 20: FDA Regulatory & Infection-Control Framework
FIGURE 21: CMS, CPT, APC & ASC Reimbursement Landscape
FIGURE 22: Sustainability & Medical-Waste Impact Framework
FIGURE 23: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 24: Product Category Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 25: Disposable Endoscopic Accessories & Procedure Consumables Growth Trend
FIGURE 26: Polypectomy & Endoscopic Resection Devices Growth Trend
FIGURE 27: Tissue Acquisition Devices Growth Trend
FIGURE 28: Hemostasis & Closure Devices Growth Trend
FIGURE 29: ERCP & Pancreaticobiliary Disposable Devices Growth Trend
FIGURE 30: Fully Disposable Endoscopes & Single-Use Visualization Devices Growth Trend
FIGURE 31: Procedure Type Segment Market Share Analysis, 2025 & 2035
FIGURE 32: Procedure Type Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 33: Colonoscopy & Lower GI Endoscopy Disposable Device Demand Trend
FIGURE 34: Upper GI Endoscopy Disposable Device Demand Trend
FIGURE 35: ERCP Disposable Device Demand Trend
FIGURE 36: Endoscopic Ultrasound Disposable Device Demand Trend
FIGURE 37: Advanced Therapeutic Endoscopy Disposable Device Demand Trend
FIGURE 38: Clinical Function Segment Market Share Analysis, 2025 & 2035
FIGURE 39: Clinical Function Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 40: Diagnostic Sampling & Tissue Acquisition Growth Trend
FIGURE 41: Polyp Removal & Endoscopic Resection Growth Trend
FIGURE 42: Hemostasis & Defect Closure Growth Trend
FIGURE 43: Access, Dilation & Device Delivery Growth Trend
FIGURE 44: Drainage, Stenting & Pancreaticobiliary Therapy Growth Trend
FIGURE 45: Visualization, Irrigation & Procedure Support Growth Trend
FIGURE 46: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 47: End User Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 48: Hospitals & Integrated Health Systems Market Growth Trend
FIGURE 49: Ambulatory Surgery Centers Market Growth Trend
FIGURE 50: Freestanding Endoscopy Centers Market Growth Trend
FIGURE 51: Academic Medical Centers & Tertiary GI Centers Market Growth Trend
FIGURE 52: Gastroenterology Practices & Office-Based Facilities Market Growth Trend
FIGURE 53: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 54: Procurement Channel Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 55: Direct Hospital & Health-System Procurement Growth Trend
FIGURE 56: IDN Enterprise Contracting Growth Trend
FIGURE 57: GPO Contracting Growth Trend
FIGURE 58: Distributor & Specialty Supplier Sales Growth Trend
FIGURE 59: Ambulatory & Physician-Owned Facility Procurement Growth Trend
FIGURE 60: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 61: Regional Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 62: U.S. GI Procedure Volume & Disposable Device Demand Map
FIGURE 63: West Region Market Share Analysis by State, 2025
FIGURE 64: West Region Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 65: California Disposable Gastroenterology Devices Market Growth Outlook
FIGURE 66: Washington Disposable Gastroenterology Devices Market Growth Outlook
FIGURE 67: Arizona Disposable Gastroenterology Devices Market Growth Outlook
FIGURE 68: Colorado Disposable Gastroenterology Devices Market Growth Outlook
FIGURE 69: Oregon, Utah & Nevada Market Growth Comparison
FIGURE 70: New Mexico, Idaho, Montana & Wyoming Market Growth Comparison
FIGURE 71: Alaska & Hawaii Market Growth Comparison
FIGURE 72: Northeast Region Market Share Analysis by State, 2025
FIGURE 73: Northeast Region Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 74: New York Disposable Gastroenterology Devices Market Growth Outlook
FIGURE 75: Massachusetts Disposable Gastroenterology Devices Market Growth Outlook
FIGURE 76: New Jersey & Pennsylvania Market Growth Comparison
FIGURE 77: Connecticut, Maine, Vermont & New Hampshire Market Growth Comparison
FIGURE 78: Rhode Island & Delaware Market Growth Comparison
FIGURE 79: South Region Market Share Analysis by State, 2025
FIGURE 80: South Region Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 81: Texas Disposable Gastroenterology Devices Market Growth Outlook
FIGURE 82: Florida Disposable Gastroenterology Devices Market Growth Outlook
FIGURE 83: Georgia & North Carolina Market Growth Comparison
FIGURE 84: Tennessee & South Carolina Market Growth Comparison
FIGURE 85: Alabama, Mississippi & Louisiana Market Growth Comparison
FIGURE 86: Arkansas, Kentucky & Oklahoma Market Growth Comparison
FIGURE 87: Virginia, Maryland & West Virginia Market Growth Comparison
FIGURE 88: Midwest Region Market Share Analysis by State, 2025
FIGURE 89: Midwest Region Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 90: Illinois Disposable Gastroenterology Devices Market Growth Outlook
FIGURE 91: Ohio Disposable Gastroenterology Devices Market Growth Outlook
FIGURE 92: Michigan & Minnesota Market Growth Comparison
FIGURE 93: Indiana & Wisconsin Market Growth Comparison
FIGURE 94: Missouri, Iowa & Kansas Market Growth Comparison
FIGURE 95: Nebraska, North Dakota & South Dakota Market Growth Comparison
FIGURE 96: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 97: Company Positioning Matrix
FIGURE 98: Key Player Product Portfolio Benchmarking
FIGURE 99: Single-Use Endoscopy Technology Positioning Matrix
FIGURE 100: Strategic Developments, Partnerships, M&A & Product Launches
FIGURE 101: Disposable Gastroenterology Device Innovation Roadmap
FIGURE 102: Single-Use Endoscope Adoption Roadmap
FIGURE 103: ERCP & Pancreaticobiliary Device Opportunity Map
FIGURE 104: Advanced Tissue Acquisition & Therapeutic Endoscopy Opportunity Map
FIGURE 105: Future Market Scenario Analysis, 2026–2035
FIGURE 106: Disruptive Technologies Impact Matrix
FIGURE 107: Disposable versus Reusable Endoscopy Penetration Outlook, 2025–2035
FIGURE 108: Sustainability & Circular-Economy Roadmap
FIGURE 109: Emerging Business Trends Matrix
FIGURE 110: High-Growth Product Opportunity Matrix
FIGURE 111: High-Growth State Opportunity Matrix
FIGURE 112: Market White-Space Analysis
FIGURE 113: Investment Prioritization Matrix
FIGURE 114: Strategic Growth Roadmap for U.S. Disposable Gastroenterology Device Companies
FIGURE 115: U.S. Go-to-Market Strategy Framework
FIGURE 116: GPO & IDN Contracting Strategy Framework
FIGURE 117: Product Positioning & Portfolio Expansion Framework
FIGURE 118: Pricing & Value-Based Selling Framework
FIGURE 119: State-Level Commercial Prioritization Framework
FIGURE 120: Report Scope, Forecasting & Disclaimer Framework